Effectiveness of erenumab in chronic migraine in a tertiary headache centre

被引：0
|
作者：
Khalil, Modar [1 ,2 ]
Moreno-Ajona, David [1 ,2 ]
Greenwood, Fiona [1 ,2 ]
Hoffmann, Jan [1 ,2 ]
Goadsby, Peter J. [1 ,2 ]
机构：
[1] Kings Coll London, NIHR Wellcome Trust Kings Clin Res Facil, London, England
[2] Kings Coll London, SLaM Biomed Res Ctr, London, England
来源：
CEPHALALGIA | 2019年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
IHC-PO-412
引用
收藏
页码：269 / 270
页数：2
相关论文
共 50 条
  • [21] Real-life assessment of erenumab in refractory chronic migraine with medication overuse headache
    Umberto Pensato
    Carlo Baraldi
    Valentina Favoni
    Maria Michela Cainazzo
    Paola Torelli
    Pietro Querzani
    Alessia Pascazio
    Davide Mascarella
    Eleonora Matteo
    Simone Quintana
    Gian Maria Asioli
    Pietro Cortelli
    Giulia Pierangeli
    Simona Guerzoni
    Sabina Cevoli
    Neurological Sciences, 2022, 43 : 1273 - 1280
  • [22] Effectiveness of Erenumab-aooe, Fremanezumab-vfrm and Galcanezumab-gnlm in Migraine Patients at Tertiary Headache Clinic with Emphasis on High-Frequency Migraine Patients
    McCurry, Roxanne
    Krashin, Daniel
    Schorn, Melissa
    Chan-Goh, Sau Mui
    Budica, Marcel
    Murinova, Natalia
    NEUROLOGY, 2020, 94 (15)
  • [23] Pooled retrospective analysis of 70 mg erenumab in episodic and chronic migraine: a two tertiary headache centers experience during clinical practice
    P. Storch
    P. Burow
    B. Möller
    T. Kraya
    S. Heintz
    N. Politz
    S. Naegel
    Acta Neurologica Belgica, 2022, 122 : 931 - 937
  • [24] Pooled retrospective analysis of 70 mg erenumab in episodic and chronic migraine: a two tertiary headache centers experience during clinical practice
    Storch, P.
    Burow, P.
    Moller, B.
    Kraya, T.
    Heintz, S.
    Politz, N.
    Naegel, S.
    ACTA NEUROLOGICA BELGICA, 2022, 122 (04) : 931 - 937
  • [25] Erenumab efficacy in migraine headache prophylaxis: A systematic review
    Bagherzadeh-Fard, Mahsa
    Yazdanifar, Mohammad Amin
    Sadeghalvad, Mona
    Rezaei, Nima
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 117
  • [26] Effectiveness and safety of erenumab in chronic migraine: A Croatian real-world experience
    Mahovic, Darija
    Bracic, Matea
    Jakus, Lukrecija
    Cvetkovic, Vlasta Vukovic
    Krpan, Marina
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2022, 214
  • [27] Cost-effectiveness analysis of erenumab vs onabotulinumtoxinA for chronic migraine in Spain
    Pozo-Rosich, Patricia
    Poveda, Jose Luis
    Sanchez, Sergio
    Crespo, Carlos
    Martinez, Maria
    Irimia, Pablo
    CEPHALALGIA, 2022, 42 (1_SUPPL) : 118 - 119
  • [28] Descriptive analysis of a population with chronic migraine in a tertiary Headache Center
    Martins, Ana-Ines
    Ramos-Lopes, Joana
    Lopes, Pedro
    Silva, Bruno
    Batista, Sonia
    Sousa, Livia
    Luzeiro, Isabel
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [29] Erenumab in Chronic Migraine: An Australian Experience
    Cheng, Shuli
    Jenkins, Bronwyn
    Limberg, Nicole
    Hutton, Elspeth
    HEADACHE, 2020, 60 (10): : 2555 - 2562
  • [30] Erenumab for the treatment of chronic resistant migraine
    Layos-Romero, Almudena
    Lopez, Alberto Andres
    Bartolome, Laura Rojas
    MEDICINA CLINICA, 2022, 158 (02): : 96 - 97
12345